Insulin Resistance: The Ten-Year Warning Most Bloodwork Ignores
By Dr. Brandon Nader, DO · Founder & Medical Director
Type 2 diabetes is often described as a disease that develops suddenly in middle age. It is more accurate to describe it as a disease that is diagnosed suddenly, after developing quietly for ten to fifteen years.
During those years, the pancreas compensates for growing insulin resistance by secreting more insulin. Fasting glucose, the marker on nearly every standard panel, stays stubbornly normal because the body is winning an escalating war. By the time glucose rises, beta-cell compensation is failing and substantial metabolic damage is done.
Measuring the war, not the outcome
Fasting insulin, HOMA-IR, and the triglyceride-to-HDL ratio reveal the compensation itself. An insulin of 15 µIU/mL with a normal glucose is not reassuring; it is a decade of advance notice. Continuous glucose monitoring adds the dynamic picture: post-meal excursions and glucose variability that a single fasted draw can never show.
The encouraging part: early insulin resistance is among the most reversible conditions in medicine. Resistance training, protein-forward nutrition, sleep repair, and, where appropriate, targeted pharmacotherapy can restore insulin sensitivity measurably within months. We know because we re-test.
The practical takeaway
If your bloodwork has only ever included fasting glucose and HbA1c, you have not been screened for insulin resistance; you have been screened for its end stage. Ask for a fasting insulin. The earlier the answer, the easier the fix.
This article is educational and does not constitute medical advice. Decisions about testing and treatment should be made with your physician in the context of your personal history.